Bringing new drugs to untreatable diseases

The Drug Discovery World Podcast

Conteúdo fornecido por Drug Discovery World and Drug Discovery World (DDW). Todo o conteúdo do podcast, incluindo episódios, gráficos e descrições de podcast, é carregado e fornecido diretamente por Drug Discovery World and Drug Discovery World (DDW) ou por seu parceiro de plataforma de podcast. Se você acredita que alguém está usando seu trabalho protegido por direitos autorais sem sua permissão, siga o processo descrito aqui https://pt.player.fm/legal.

1y ago 13:33

MP3•Home de episódios

In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.

In this latest episode, DDW's Megan Thomas is in conversation with Dr Simon Fricker, who just last year was made Chief Development Officer of PepperBio to support the company’s next phase of growth and guide the strategic expansion of Pepper’s oncology pipeline.

Over the course of his career, including eight years as a distinguished scientific fellow at Genzyme/Sanofi, Dr. Fricker worked on three approved drugs: Paraplatin, Fosrenol, and Mozobil. Dr. Fricker was a founder of Canadian biopharma company AnorMED, acquired by Genzyme, and awarded the Queen’s Award for Technology for his participation in the development of the anticancer drug Paraplatin.

153 episódios

#Drugdevelopment #Drugdiscovery #Enablingtechnologies #Healthcare #Personalisedmedicine #Pharma #Biology #Informatics #Fitness #Drug Discovery World #Biopharma #Pharmacology #Science #Medicine #Business #Therapeutics #Drug Discovery World DDW #Screen